The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Irish Pharmaceutical Healthcare Association naming Stephen Donnelly .

Filed returns
26
match these filters
Matching filed returns per period 0 1 2 3 5 Sep–Dec 2015: 1 filed returns Jan–Apr 2018: 2 filed returns May–Aug 2018: 2 filed returns Sep–Dec 2018: 1 filed returns Jan–Apr 2019: 2 filed returns May–Aug 2019: 2 filed returns Jan–Apr 2020: 2 filed returns May–Aug 2020: 1 filed returns Jan–Apr 2021: 1 filed returns Jan–Apr 2022: 1 filed returns May–Aug 2022: 3 filed returns Sep–Dec 2022: 1 filed returns Jan–Apr 2023: 1 filed returns May–Aug 2023: 2 filed returns Sep–Dec 2023: 2 filed returns Jan–Apr 2024: 1 filed returns May–Aug 2024: 1 filed returns 2018 2019 2020 2021 2022 2023 2024
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2024 Irish Pharmaceutical Healthcare Association Health (i) Proposed revision of EU General Pharmaceutical Legislation, particularly items relating to incentives/intellectual property rights; (ii) EU wide access to new medicines. (Legislation) 10 On lobbying.ie
Jan–Apr 2024 Irish Pharmaceutical Healthcare Association Health (1) Budget 2024 - the need for funding of new medicines. (2) Likely no provision for new developments funding to HSE for new medicines in Budget 2024. (3) Absence of funding for new medicines in Budget 2024. (4)… (Matters involving public funds) 34 On lobbying.ie
Sep–Dec 2023 Irish Pharmaceutical Healthcare Association Health (1) Reimbursement process improvements under consideration in the Mazar's Working Group. (2) Delays within Medicines Reimbursement System. (3) Preparation for negotiation of a Framework Agreement in 2025. (4) Process… (Public policy or programme) 16 On lobbying.ie
Sep–Dec 2023 Irish Pharmaceutical Healthcare Association Health Review of EU Council and Parliament process for proposed amendments to pharmaceutical legislation. (Legislation) 2 On lobbying.ie
May–Aug 2023 Irish Pharmaceutical Healthcare Association Health Budget 2024 - Exchequer allocation to HSE for new medicines expenditure in 2024. (Matters involving public funds) 3 On lobbying.ie
May–Aug 2023 Irish Pharmaceutical Healthcare Association Health Matters under consideration that the European EPSCO Council in June, including the proposed revision of the General Pharmaceutical Legislation. (Legislation) 1 On lobbying.ie
Jan–Apr 2023 Irish Pharmaceutical Healthcare Association Health Revision of pharmaceutical legislation by European Commission. (Legislation) 10 On lobbying.ie
Sep–Dec 2022 Irish Pharmaceutical Healthcare Association Health Congratulations on appointment. Seek support for fast access to new medicines and for innovation in the EU Pharmaceutical Strategy. (Public policy or programme) 6 On lobbying.ie
May–Aug 2022 Irish Pharmaceutical Healthcare Association Health Discussion on EU pharmaceutical strategy and other matters. (Public policy or programme) 1 On lobbying.ie
May–Aug 2022 Irish Pharmaceutical Healthcare Association Health Budget submission (Public policy or programme) 2 On lobbying.ie
May–Aug 2022 Irish Pharmaceutical Healthcare Association Health Gas supplies and pharmaceutical production. (Legislation) 4 On lobbying.ie
Jan–Apr 2022 Irish Pharmaceutical Healthcare Association Health (i) EU Pharmaceutical Policy; (ii) EFPIA WAIT Indicator Survey - Access to new medicines; (iii) Access to Orphan Medicines; (iv) EU Pharmaceutical Strategy (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2021 Irish Pharmaceutical Healthcare Association Health Extension of framework agreement on medicines. (Public policy or programme) 14 On lobbying.ie
May–Aug 2020 Irish Pharmaceutical Healthcare Association Health Government policy on access to new medicines (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2020 Irish Pharmaceutical Healthcare Association Health Importance of a definitive and focused medicines policy, especially regarding access, in the Programme for Government (Public policy or programme) 12 On lobbying.ie
Jan–Apr 2020 Irish Pharmaceutical Healthcare Association Health Importance of medicines policy in General Election dialogue (Public policy or programme) 2 On lobbying.ie
May–Aug 2019 Irish Pharmaceutical Healthcare Association Health PwC report for EFPIA on value of pharmaceutical industry (Public policy or programme) 11 On lobbying.ie
May–Aug 2019 Irish Pharmaceutical Healthcare Association Health IPHA Manifesto for Better Health (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health IPHA policy document "Manifesto for Better Health" (Public policy or programme) 14 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health Originator pharmaceutical industry's preparations for Brexit (Public policy or programme) 9 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health IPHA 'Manifesto for Better Health' (Public policy or programme) 25 On lobbying.ie
May–Aug 2018 Irish Pharmaceutical Healthcare Association Health Briefing of Fianna Fáil Spokesperson on Health, Stephen Donnelly TD (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Irish Pharmaceutical Healthcare Association Health IPHA political series with Health spokespersons (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2018 Irish Pharmaceutical Healthcare Association Health To arrange meetings with senior Fianna Fáil front benchers, including Party Leader Micheál Martin TD (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2018 Irish Pharmaceutical Healthcare Association Health IPHA political series with Health Spokspersons (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2015 Irish Pharmaceutical Healthcare Association Health IPHA policy priorities as set out in "Policy and Budgetary Perspectives 2015 - 2016" document (Public policy or programme) 21 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 26 100.0%